Gil Blum
Stock Analyst at Needham
(4.69)
# 756
Out of 4,453 analysts
697
Total ratings
43.9%
Success rate
14.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintained: Buy | $82 | $54.26 | +51.12% | 41 | Jun 24, 2026 | |
| ABSI Absci | Reiterated: Buy | $7 → $11 | $10.45 | +5.26% | 13 | Jun 24, 2026 | |
| TCRX TScan Therapeutics | Reiterated: Buy | $6 | $0.8294 | +623.41% | 17 | Jun 23, 2026 | |
| TSHA Taysha Gene Therapies | Reiterated: Buy | $12 | $6.23 | +92.77% | 48 | Jun 22, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $34 | $22.43 | +51.62% | 46 | Jun 15, 2026 | |
| LYEL Lyell Immunopharma | Maintained: Buy | $44 | $12.51 | +251.72% | 5 | Jun 15, 2026 | |
| RNAC Cartesian Therapeutics | Reiterated: Buy | $40 | $8.96 | +346.68% | 36 | Jun 9, 2026 | |
| ARTV Artiva Biotherapeutics | Reiterated: Buy | $41 | $8.85 | +363.28% | 15 | Jun 8, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | n/a | $1.83 | - | 22 | Jun 4, 2026 | |
| CELC Celcuity | Reiterated: Buy | $157 | $97.87 | +60.42% | 32 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $30.60 | +145.10% | 22 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $8.90 | +113.48% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.60 | +525.00% | 50 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 | $2.83 | +288.69% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3088 | +871.50% | 34 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.25 | - | 49 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $16.04 | - | 55 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $3.36 | +138.10% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.39 | +188.81% | 35 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.95 | - | 28 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.61 | - | 25 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.70 | n/a | 15 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 400.00 → kr 371.00 | $178.00 | n/a | 16 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $30.76 | n/a | 14 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $88.65 | n/a | 10 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 5 | Apr 6, 2022 |
CRISPR Therapeutics AG
Jun 24, 2026
Maintained: Buy
Price Target: $82
Current: $54.26
Upside: +51.12%
Absci
Jun 24, 2026
Reiterated: Buy
Price Target: $7 → $11
Current: $10.45
Upside: +5.26%
TScan Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $6
Current: $0.8294
Upside: +623.41%
Taysha Gene Therapies
Jun 22, 2026
Reiterated: Buy
Price Target: $12
Current: $6.23
Upside: +92.77%
Nurix Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $34
Current: $22.43
Upside: +51.62%
Lyell Immunopharma
Jun 15, 2026
Maintained: Buy
Price Target: $44
Current: $12.51
Upside: +251.72%
Cartesian Therapeutics
Jun 9, 2026
Reiterated: Buy
Price Target: $40
Current: $8.96
Upside: +346.68%
Artiva Biotherapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $41
Current: $8.85
Upside: +363.28%
Fate Therapeutics
Jun 4, 2026
Maintained: Hold
Price Target: n/a
Current: $1.83
Upside: -
Celcuity
Jun 2, 2026
Reiterated: Buy
Price Target: $157
Current: $97.87
Upside: +60.42%
Jun 1, 2026
Maintained: Buy
Price Target: $75
Current: $30.60
Upside: +145.10%
May 14, 2026
Reiterated: Buy
Price Target: $19
Current: $8.90
Upside: +113.48%
May 14, 2026
Maintained: Buy
Price Target: $10
Current: $1.60
Upside: +525.00%
May 13, 2026
Rated: Buy
Price Target: $11
Current: $2.83
Upside: +288.69%
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3088
Upside: +871.50%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $3.25
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $16.04
Upside: -
May 7, 2026
Rated: Buy
Price Target: $8
Current: $3.36
Upside: +138.10%
May 6, 2026
Maintained: Buy
Price Target: $4
Current: $1.39
Upside: +188.81%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $5.95
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.61
Upside: -
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $1.70
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: kr 400.00 → kr 371.00
Current: $178.00
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $6
Current: $30.76
Upside: n/a
Aug 25, 2022
Rated: Hold
Price Target: n/a
Current: $88.65
Upside: n/a
Jun 3, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 6, 2022
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a